Characterization of a  sexual stage antigen PbPH as a new candidate for malaria transmission-blocking vaccine by unknown
RESEARCH Open Access
Characterization of a Plasmodium berghei
sexual stage antigen PbPH as a new
candidate for malaria transmission-blocking
vaccine
Xu Kou1,2, Wenqi Zheng1, Feng Du1, Fei Liu3, Meilian Wang1, Qi Fan4, Liwang Cui5, Enjie Luo1* and Yaming Cao3*
Abstract
Background: Transmission-blocking vaccines (TBVs) are a promising strategy for malaria control and elimination.
However, candidate TBV antigens are currently limited, highlighting the urgency of identifying new antigens for
TBV development.
Methods: Using a combination of bioinformatic analysis and functional studies in the rodent malaria model
Plasmodium berghei, we identified a conserved Plasmodium protein PbPH (PBANKA_041720) containing a pleckstrin
homology (PH) domain. The expression of PbPH was detected by Western blot and indirect immunofluorescence
assay (IFA). The function of PbPH was tested by genetic knockout. The TB activity was confirmed by in vitro
ookinete conversion assay and mosquito feeding.
Results: PbPH was detected in Western blot as highly expressed in sexual stages (gametocytes and ookinetes).
IFA revealed localizations of PbPH on the surface of gametes, zygotes, and ookinetes. Deletion of the pbph gene
did not affect asexual growth, but significantly reduced the formation of gametocytes, ookinetes, and oocysts,
indicating that PbPH protein is required for parasite sexual development. Recombinant PbPH expressed and
purified from bacteria elicited strong antibody responses in mice and the antibodies significantly inhibited
exflagellation of male gametocytes and formation of ookinetes in a concentration-dependent manner. Mosquito
feeding experiments confirmed that mosquitoes fed on mice immunized with PbPH had 13 % reduction in the
prevalence of infection and almost 48 % reduction in oocyst density.
Conclusions: Pbph is a highly conserved Plasmodium gene and is required for parasite sexual development. PbPH
protein is expressed on the surface of gametes and ookinetes. Immunization of mice against the recombinant PbPH
protein induced strong antibody responses that effectively reduced the formation of male gametes and ookinetes
in vitro and blocked transmission of the parasites to mosquitoes. These results highlight PbPH as a potential TBV
candidate that is worth future investigations in human malaria parasites.
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Background
Malaria, transmitted by Anopheles mosquitoes, is one of
the world’s most challenging public health problems.
While insecticide-treated nets, antimalarial drugs, and
indoor residual sprays of insecticides have together con-
tributed to a significant decrease in the incidence of
malaria in many parts of world [1], the emergence and
spread of drug-resistant parasites and insecticide-resistant
mosquitoes are ever-present risks that potentially threaten
the recent gains in malaria control. Interruption of malaria
transmission from host to mosquito has been recognized
as one of the greatest challenges in malaria elimination
[2]. Novel tools that specifically reduce the transmission
of malaria parasites from humans to mosquitoes are ur-
gently needed for this purpose. Transmission-blocking
vaccines (TBVs) targeting sexual and/or sporogonic devel-
opment of the parasite and designed to prevent malaria
transmission in endemic regions are a potentially highly
effective strategy especially during malaria elimination [3].
TBVs are aimed at blocking malaria transmission by
interrupting the parasite’s life - cycle in the mosquito. The
fundamental principle of TBVs is immunization of humans
with surface antigens of sexual- and mosquito-stage para-
sites to produce antibodies that arrest subsequent develop-
ment of the parasite in the mosquito midgut, thus cutting
off the transmission of malaria parasites [4]. Alternatively,
TBV may target mosquito antigens that are required for
successful development of the parasite in its vector [5].
TBVs do not directly protect vaccinated individuals from
the disease but, rather, protect communities from the
spread of malaria. Careful selections of candidate antigens
are essential for the development of TBVs. For parasite
antigens, the TBV candidates should be localized on the
surface of sexual- and mosquito-stage parasites (i.e.
gametocyte, gamete, zygote, and ookinete) [6, 7]. To date,
several TBV targets have been investigated, and they have
distinct characteristics [8, 9]. Antibodies raised against
Pfs230 can prevent oocyst development and also lyse gam-
etes in a complement-dependent manner [10]. Antibodies
against the male gamete antigen P48/45 are found in
human sera from endemic areas and correlate with trans-
mission blocking (TB) activities [11]. Antisera against native
or heterologously expressed major ookinete surface anti-
gens P25 or P28 completely inhibit parasite development in
mosquitoes [12]. However, most of the existing TBV candi-
dates have been found to be suboptimal [13], and therefore,
there is a real need for TBV antigen discovery.
In this study, we mined the Plasmodium database and
identified a highly conserved Plasmodium gene referred to
as PbPH, which encodes a hypothetical protein expressed
in sexual stages. We confirmed the expression of this pro-
tein in P. berghei sexual stages and localized it on the sur-
face of gametes and ookinetes. We further evaluated its
functions during sexual development by genetic knockout.
Immunization of mice against recombinant PbPH protein
induced strong antibody responses that effectively blocked
transmission of the parasites to mosquitoes.
Methods
Bioinformatics
The pbph genomic sequences used in this study were
retrieved from PlasmoDB, (http://www.plasmodb.org).
Putative signal peptide and functional domains were predi-
cated using the SMART online server (http://smart.embl-
heidelberg.de/). The presence of a potential GPI anchor in
this protein was predicted using PredGPI (http://gpcr2.
biocomp.unibo.it/gpipe/). Multiple sequence alignments
were performed using the ClustalW multiple sequence
alignment program.
Mice, parasites and mosquitoes
This study used six, eight-week old female BALB/c mice
and the Plasmodium berghei (ANKA strain 2.34). Mice
were purchased from Beijing Animal Institute (Beijing,
China). Anopheles stephensi (Hor strain) mosquitoes were
reared at 25 °C, 50–80 % humidity using a 12 h light dark
cycle in an insectary, and fed a 10 % (w/v) glucose solution.
Ethical approval
Animal use was carried out following the guidelines of the
animal ethics committee of China Medical University.
Cloning, expression and purification of PbPH
P. berghei RNA was extracted from P. berghei-infected
mouse blood 4 days after infection, and cDNA was syn-
thesized using an RNA-to-cDNA kit (Takara). The pbph
gene was amplified with primers pbph-F and pbph-R
(Additional file 1, Table S1) using P. berghei cDNA as
the template. The PCR fragment was cloned into the ex-
pression vector pET30a (+) at the NdeI and HindIII sites
and transformed in Escherichia coli BL-21. Protein
expression was induced at 20 °C for 12 h in the presence
of isopropyl-β-D-thiogalactoside (Promega) at a final
concentration of 1 mM and 1 % anhydrous D-glucose.
Bacterial cells were lysed on ice by sonication for 15 -
cycles (20 s pulses with 30 s intervals between each cycle)
and the resultant suspension passed through a 0.22-μm
filter. The filtered supernatant was loaded onto a Ni-NTA
His•Bind Superflow column (Millipore) and purified ac-
cording to the manufacturer’s protocol. Purified protein
was dialyzed overnight in phosphate buffered saline (PBS,
pH 7.2) containing 0.2 mM PMSF at 4 °C and an aliquot
was analyzed on a 12 % SDS-PAGE gel. Protein samples
were quantified using a Bradford assay.
Immunization and anti-PbPH serum
Six, eight-week old female BALB/c mice (n = 6) were im-
munized by subcutaneous injection of 40 μg recombinant
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protein emulsified in complete Freund’s adjuvant on day 0
[14], followed by two booster injections (at two-week
intervals) with the same amount of protein, respectively.
Control mice (n = 6) were injected with PBS using the
same immunization procedure. Before each immunization
and 10 days after the last immunization, blood was col-
lected from the tail vein of each mouse and allowed to clot
at room temperature.
Antiserum titers against PbPH were analyzed by
ELISA as previously described [15]. A 96-well plate was
coated with the recombinant PbPH protein at 10 μg/mL
overnight at 4 °C, and then blocked with 5 % skim milk
in 1 × PBS, 0.05 % Tween 20 (PBS-T) for 2 h at room
temperature. Mouse antiserum was diluted in PBS con-
taining 10 % calf serum albumin (pH 7.2), added to the
wells, and incubated for 2 h at 37 °C. After two washes
with TBS-T, HRP-conjugated goat anti-mouse IgG anti-
bodies (Invitrogen) diluted 1:5000 was added and incu-
bated for 2 h at 37 °C. After five washes with PBS-T, the
chromogenic substrate was added and developed for
5 min. The reaction was stopped by adding 50 μL of
2 mM H2SO4 to each well. The plate was immediately
read with a plate reader at 490 nm.
Parasite collection, lysate preparation and Western blot
For the collection of schizonts, female BALB/c mice
were injected intraperitoneally (i.p.) with 0.2 mL of
6 mg/mL phenylhydrazine in 0.9 % NaCl, 3 days prior to
infection. Infection was initiated by injection of 200 μl of
mouse blood containing 1 × 106P. berghei-infected red
blood cells (iRBCs). Four days post-infection, when the
parasitemia reached approximately 1 %, mice were anes-
thetized and heparinized blood collected in a 50 mL
tube containing 20 mL of blood-stage culture medium
(RPMI 1640, 50 mg/L penicillin, 50 mg/L streptomycin,
100 mg/L neomycin, 20 % [v/v] heat-inactivated fetal calf
serum [FCS]). The blood and culture medium were
mixed and placed in flasks then incubated in 10 % O2,
5 % CO2 and 85 % N2 at 37 °C, overnight [16]. The cul-
ture was then fractionated on a 55 % (v/v) Nycodenz
culture gradient medium. To collect gametocytes, mice
were treated with sulfadiazine (20 mg/L in drinking
water) four days post-P. berghei infection for two days to
eliminate asexual stage parasites. Six days post-infection,
parasites were harvested and kept on ice to avoid pre-
mature activation and then separated on a 48 % (v/v)
Nycodenz in RPMI 1640 culture medium gradient [17].
Gametocytes were harvested from the interface and
washed twice in RPMI 1640. For ookinete collection,
mice were bled by cardiac puncture under terminal
anesthesia three days post-P. berghei infection. Blood
was passed through a CF11 cellulose (Whatman) column
pre-equilibrated with complete ookinete culture medium
(RPMI 1640, 50 mg/L penicillin, 50 mg/L streptomycin,
100 mg/L neomycin, 20 % [v/v] heat-inactivated FCS, 6
U/mL heparin, pH 8.3). The eluate was diluted 1:10 with
complete ookinete medium into a wide flask to a max-
imum depth of 1 cm and kept at 19 °C for 24 h [18].
Parasites were then purified on a 62 % (v/v) Nycodenz/
ookinete culture medium gradient.
After collection, parasite pellets were washed twice with
PBS containing protease inhibitors (PBS-PI) and proteins
were extracted with PBS-PI containing 2 % SDS for
30 min at room temperature [19]. Equal amounts of para-
site antigens (10 μg) were electrophoresed on a 12 % SDS-
PAGE gel and transferred to a 0.22-μm PVDF membrane
(Bio-Rad). The membrane was incubated with mouse
anti-PbPH antiserum at 1:200 in Tris-buffered saline
containing 0.1 % Tween 20 (TBST) for 3 h at room
temperature, washed three times in TBST, and then incu-
bated for 2 h at 37 °C with HRP-conjugated goat anti-
mouse IgG antibodies (Invitrogen) diluted at 1:5,000 in
TBST. Proteins on the blot were visualized with a Pierce
ECL Western Blotting Kit (Thermo Scientific).
Indirect immunofluorescence assay (IFA)
P. berghei asexual stages, gametocytes and subsequent
developmental stages (gametes, zygotes and ookinetes)
were fixed with 4 % paraformaldehyde in PBS for 15 min
at room temperature, rinsed with 50 mM glycine in PBS,
and blocked with PBS containing 5 % skimmed milk for
60 min at 37 °C. Slides were incubated with mouse anti-
PbPH sera (1:200) or anti-Pbs21 mAb (clone 13.1, 1:500)
at 37 °C for 60 min, washed 3 times in PBS, and then
incubated with FITC-labeled goat anti-mouse IgG
(1:500, Invitrogen) at 37 °C for 30 min. Parasite nuclei
were counter-stained with 1 μg/mL of 4′, 6-diamidino-
2-phenylindole (DAPI; Invitrogen) [20]. Slides were then
mounted with ProLong® Gold anti-fade reagent (Invitrogen)
and visualized by fluorescence microscopy. Images were
captured and processed on a Zeiss Axio Observer Z2 using
Axiovision software and Adobe Photoshop.
Generation of pbph knockout parasites
The pbph gene was knocked out using the double-
crossover homologous recombination technology as previ-
ously described [21]. A 777-bp upstream region was
amplified by PCR from P. berghei genomic DNA using
KOD Plus DNA polymerase (Toyobo) with primers 5UTR-
F and 5UTR-R (Additional file 1, Table S1), while the 772-
bp downstream fragment was amplified with primers
3UTR-F and 3UTR-R (Additional file 1, Table S1). Subse-
quently, the 777-bp fragment was digested by HindIII and
PstI and the 772-bp fragment were digested by XhoI and
EcoRI. The digested PCR products were inserted into the
PL0034 plasmid to flank the hdhfr expression cassette. The
plasmid (10 μg) was linearized with XhoI and electroporated
into cultured P. berghei schizonts using the Nucleofector II.
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Transfected parasites were delivered into female BALB/c
mice by intravenous injection and mice were treated with
pyrimethamine (70 μg/mL) 24 h later via drinking water.
Infected blood was collected to examine the integration of
the disruption cassette by PCR using integration-specific
primers (Additional file 1, Table S1). Parasites were cloned
by limiting dilution.
Phenotypic analysis of Δpbph parasites during asexual
and sexual stages
To study the functions of PbPH during Plasmodium
sexual development, ten mice were pre-treated with
phenylhydrazine. Five mice each were injected with 1 ×
106 Δpbph-iRBCs, while the other five were injected
with 1 × 106 wild type P. berghei-iRBCs. Parasitemia was
monitored daily by Giemsa-stained blood smears. On
day 3 after infection, gametocytemia (mature gameto-
cytes per 100 RBCs) and gametocyte sex ratio were de-
termined by Giemsa-stained, tail blood smears [22].
Exflagellation of male gametocytes was quantified as de-
scribed [23]. Briefly, 10 μl of gametocyte-infected blood
was obtained from the tail vein and mixed immediately
with 90 μl of complete ookinete culture medium. The
mixture was placed under a Vaseline-coated coverslip at
25 °C, and 15 min later exflagellation centers were
counted over the next 10 min under a phase contrast
microscope. Similarly, ookinete formation was deter-
mined using 10 μl of blood collected from the tail vein
of each mouse, which was drawn into 90 μl ookinete
culture medium and incubated at 19 °C for 24 h. Cul-
tured ookinetes were labeled with a mouse anti-Pbs21
antibody (1:500) and enumerated under a fluorescence
microscope.
For mosquito feeding experiment, starved A. stephensi
mosquitoes (~50/mouse) were allowed to feed on the in-
fected mice at three days post-infection for 30 min [24, 25].
Unfed mosquitoes were removed and fed mosquitoes were
maintained at 19–22 °C and in 50–80 % relative humidity.
For each mouse, up to 30 mosquitoes were dissected
10 days after feeding. The midguts were stained with 0.5 %
mercurochrome (Sigma-Aldrich). Oocysts were counted to
determine the prevalence of infection (number of infected
mosquitoes) and the intensity of infection (number of
oocysts per positive midgut).
Quantification of TB activity
To determine whether immune sera against PbPH affect
exflagellation of male gametocytes, 10 μl of infected
mouse blood was mixed with the ookinete culture
medium containing anti-PbPH mouse sera or control
sera at final dilutions of 1:5, 1:10 and 1:50. Quantifica-
tion of exflagellation centers was performed as described
above.
For the in vitro ookinete conversion assay, mice were
treated with phenylhydrazine and inoculated i.p. with
0.2 ml of infected blood containing 1 × 106 P. berghei
parasites. Blood was collected from mice three days after
infection. After removal of the serum, blood was reconsti-
tuted using control sera or sera from mice immunized
with the recombinant PbPH protein at 1:5, 1:10, and 1:50
dilution with the complete ookinete culture medium [26,
27]. Parasites were cultured in vitro at 19 °C for 24 h. The
cultures were fixed, labeled with Pbs21 mAb (1:500), and
ookinete numbers quantified under a fluorescence micro-
scope. Sera from female BALB/c mice injected with PBS
were used as negative controls.
For mosquito feeding experiment, two groups of mice
(n = 5) were immunized with recombinant PbPH protein
or PBS (negative control) as described above. Seven days
after the final boost, all mice were treated with phenyl-
hydrazine, and infected i.p. with 1 × 106 P. berghei iRBC.
Mosquito feeding and oocyst counting were performed
as described above.
Statistical analyses
Statistical comparison between groups (IgG levels, parasit-
emia, gametocytemia, ookinete numbers) was made by
Student’s t test using the GraphPad Prism software. The
intensity of infection (oocysts/midgut) was analyzed using
Mann–Whitney U test, while infection prevalence was an-
alyzed by Fisher’s exact test using SPSS version 17.0.
Results
PbPH is highly conserved among Plasmodium species
Through bioinformatic analysis using criteria of protein
expression in sexual stages and the presence of a puta-
tive signal peptide, we identified a P. berghei gene
PBANKA_041720 from the Plasmodium database. This
gene is located on chromosome 4, encoding a protein of
286 amino acids with a calculated molecular weight of
33 kDa. The predicted protein contains a signal peptide
and a pleckstrin homology (PH) domain (Fig. 1b), and
therefore, it is referred to as PbPH. PH domains are
small modular domains that occur in a large variety of
eukaryotic signaling proteins. The domains can bind to
phosphatidylinositol in biological membranes and also
to proteins such as protein kinase C [28]. Through such
interactions, PH domains recruit proteins to different
membranes and target them to appropriate cellular
compartments or enable them to interact with other
components of a signal transduction pathway [27, 29,
30]. PredGPI did not predict the presence of a GPI
anchor within PbPH. Multiple sequence alignments
using a ClustlW showed that this PH domain protein is
highly conserved among Plasmodium species and PH
domain is the most homologous sequence (Fig. 1a).
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PbPH is expressed in sexual stages
The recombinant PbPH protein was expressed in E. coli
as His-tagged protein and purified by affinity chroma-
tography using Ni-NTA resin. SDS-PAGE analysis re-
vealed that the recombinant PbPH protein had a
molecular weight of approximately 33 kDa, consistent
with the predicted molecular size of PbPH (Fig. 2a). The
recombinant PbPH was used to immunize mice to
produce polyclonal antibodies. ELISA showed that mice
developed a strong antibody response against recombin-
ant PbPH. Antibody titers increased over time following
the initial immunization, with substantial boosting ob-
served in the two subsequent immunizations. Antibody
titers were significantly higher than those from PBS
control (t(4) =10.21, P = 0.0005; Fig. 2b) and it reached a
titer of 1:25600 after the third immunization. This re-
sult indicated that the recombinant PbPH was highly
immunogenic and successfully induced the production
of specific antibodies in mice.
To determine whether these antibodies are reactive
with the native PbPH protein in P. berghei, Western blot
was performed with parasite lysates from purified
schizonts, gametocytes and ookinetes. The anti-PbPH
antisera primarily recognized a band at approximately
33 kDa in purified gametocytes and ookinetes (Fig. 3a).
Only a very faint band was detected in schizonts, which
may be due to the small number of contaminating
gametocytes. This is consistent with the published P.
berghei proteome data showing that the PbPH protein is
expressed in gametocytes and ookinetes [31, 32]. This
result also confirmed that the anti-PbPH sera recognized
the native parasite antigen.
The localization of PbPH in the asexual and sexual
stages of P. berghei was investigated by IFA. Whereas no
signal was detected in schizonts, strong fluorescence was
observed in male and female gametocytes, and on the sur-
faces of male and female gametes, zygotes, retorts and
ookinetes (Fig. 3b). Also consistent with the Western blot,
strongest fluorescence was observed in gametocytes and
gametes. Compared with the surface location of Pbs21,
the PbPH localization on the ookinete surface was less
homogeneous. Surface localization is consistent with the
presence of a signal peptide in PbPH and indicates that
this protein is secreted in sexual stages.
A                                                           
B
Fig. 1 Bioinformatic analyses of PbPH. a Alignment of protein sequences of PH domain proteins in Plasmodium species: P. berghei (Pb), P.
falciparum (Pf), P. yoelii (Py), P. chabaudi (Pc), P. vivax (Pv), and P. knowlesi (Pk). Amino acids conserved across six species are marked: identical
(black), similar (gray). The PH domain is highlighted. b Schematic diagram of PbPH showing the locations of a signal peptide (red) and a PH
domain (blue). The E. coli expression segment shows amino acids 21 to 286
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Fig. 2 Recombinant PbPH protein purification and immunization. a Purified recombinant proteins were subjected to electrophoresis on a 12 %
SDS-PAGE gel. M: PageRuler Prestained Protein Ladder in kDa. b ELISA showing the PbPH-antibody titers after immunizations. Serum samples
were collected post-immunization on days 14, 28, and 38. Titers correspond to the last dilution of the test serum in which OD490 values were
above that of the cut-off. The cut-off value was defined as that of pooled sera from native mice. Serum samples were tested at two-fold serial
dilutions (1 × 102–2 × 105). Pooled sera from native mice were used as a negative control. Results are representative of three independent experiments.
The error bars indicate mean ± SEM (n = 3). **P < 0.01 (Student’s t test)
A B
Fig. 3 Expression and localization of PbPH in the parasites. a Western blot of PbPH in asexual- and sexual-stage parasites. Parasite antigens of
schizonts, gametocytes, and ookinetes (10 μg/lane) were incubated with anti-PbPH sera (1:200) from immunized mice. Protein loading is estimated
using anti-Hsp70 serum (1:200). b IFA analysis. Blood smears containing parasite samples were stained at different times after collection of P. berghei-in-
fected blood. Parasites were fixed and stained with anti-PbPH sera (1:200) from recombinant PbPH-immunized mice and then with FITC-conjugated
goat anti-mouse IgG (green). Nuclei were stained by DAPI (blue). Pbs21 mAb clone 13.1 serves as a positive control. Scale - bar: 5 μm
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PbPH is needed for sexual development in P. berghei
To study the functions of PbPH in parasite development, the
pbph gene was knocked out by homologous recombination
(Fig. 4a). Pbph knockout-lines (Δpbph) were selected by
pyrimethamine and cloned by limiting dilution. After clon-
ing, deletion of the pbph gene was confirmed by integration-
specific PCR in three clones (Fig. 4b). Phenotypic compari-
son between the wild-type and Δpbph parasite was per-
formed in both asexual and sexual stages. Consistent with
the lack of pbph expression in asexual erythrocytic stages,
deletion of the pbph gene in P. berghei did not result in a
noticeable difference in parasitemia as compared with the
wild-type parasite (Fig. 5a), indicating that PbPH is dispens-
able during the asexual stages of the parasites. However,
compared to the wild type, the Δpbph line displayed a signifi-
cantly reduced production of gametocytes (t(8) = 3.63, P =
0.0067; Fig. 5b). Gametocytemia had a 1.8 fold reduction in
the Δpbph parasites compared with the wild type. Deletion
of pbph appeared to have affected the formation of both
male and female gametocytes, since there was no significant
difference in sex ratio between the wild-type and Δpbph
parasites (Fig. 5c). To determine the function of pbph in
subsequent sexual development, we quantified exflagellation
and ookinete conversion from the same numbers of gameto-
cytes. The results showed that the Δpbph line displayed a
~31 % reduction in exflagellation centers per field (t(8) =
4.81, P = 0.0013; Fig. 5d). Ookinete conversion in vitro was












Fig. 4 Knockout of pbph gene from P. berghei parasite. a A schematic shows the wild type pbph locus, transfection construct, and the recombined locus.
Through a double-crossover strategy the pbph locus was replaced with the dhfr-expressing cassette. Primers 1–6 used to detect gene knockout are marked.









































































































Fig. 5 Functional analysis of PbPH during parasite development. a Mice were infected with P. berghei or Δpbph parasite and parasitemia was
monitored for 11 days. b Gametocytemias in mice infected with wild-type (WT) and Δpbph parasites. **P < 0.01 (Mann–Whitney U test). c Female:
male gametocyte ratios of WT and Δpbph parasites. d Exflagellation of male gametocytes in WT and Δpbph parasites. **P < 0.01 (Student’s t test).
e Ookinete numbers in WT and Δpbph parasites. **P < 0.01 (Student’s t test). The error bars in B-E indicate mean ± SEM (n = 5). f Oocyst numbers
per midgut in mosquitoes fed on WT and Δpbph parasites. **P < 0.01 (Mann–Whitney U test). The horizontal bars indicate the mean number of
oocysts per midgut (± SEM). All the data in the functional analysis of PbPH are representative of three independent experiments
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reduction in the Δpbph line compared to the wild-type
(t(8) = 4.74, P = 0.0015; Fig. 5e). In mosquito feeding assays,
the mean number of oocysts per midgut was reduced from
126.9 in those fed on wild-type parasites to 63.7 in those
fed on Δpbph parasites (Z = -3.41, P = 0.001; Fig. 5f). It is
noteworthy that the declines in ookinetes and oocysts could
be the result of reduced gametocyte and gamete numbers.
Antibodies against PbPH can block parasite
sexual development
To study the TB activities of the antibodies against PbPH,
we first evaluated the effect of the antibodies on the
formation of male gametes. When wild type P. berghei
gametocytes were incubated with the anti-PbPH antisera
at the 1:5 and 1:10 dilutions, male gametogenesis was
significantly affected. Compared to control sera, the
number of exflagellation centers per field were reduced by
49 and 37 % when incubated with anti-PbPH serum at
1:5 (t (4) = 5.46, P = 0.0054; Fig. 6a) and 1:10 (t (4) = 5.54,
P = 0.0051; Fig. 6a) dilutions, respectively.
Given the localization of PbPH on the surfaces of sexual
stages, we wanted to further evaluate TB activity of anti-
bodies against PbPH using an in vitro ookinete conversion
assay and mosquito feeding. In the in vitro assay, immune
sera against PbPH at all dilutions used exhibited significant
effects in blocking the formation of ookinetes (Fig. 6b). In
particular, the anti-PbPH sera at 1:5 dilution almost

































































Fig. 6 Transmission-blocking activity of PbPH. a Effect of anti-PbPH sera on exflagellation of male gametocytes. Exflagellation centers per field
were measured after 15 min incubation with anti-PbPH mice sera or control sera at final dilutions of 1:5, 1:10 and 1:50. Means were calculated
from three separate experiments. Error bars indicate mean ± SEM (n = 3). **P < 0.01 (Student’s t test). b The effect of anti-PbPH sera at 1:5, 1:10,
and 1:50 dilutions on P. berghei ookinete conversion in vitro. Means were calculated from three separate experiments. Error bars indicate mean ±
SEM (n = 3). *P < 0.05; **P < 0.01 (Student’s t test). c Direct mosquito feeding assay on control mice and mice immunized with recombinant PbPH
protein (5 mice per group). Mice were subsequently infected with wild-type P. berghei and used to assess TB activities. The data are representative
of three independent experiments. Data points represent midgut oocyst numbers of individual mosquitoes in each group. Mean number of oocysts
per midgut and the SEM are shown
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0.0001; Fig. 6b). Even at 1:50 dilution, the ookinete
number was reduced by 84 % when cultured with the
immune sera (t (4) = 12.26, P = 0.0002; Fig. 6b).
To further test the TB efficacy of antibodies induced by
recombinant PbPH in vivo, immunized mice were used to
feed An. stephensi mosquitoes. Compared to the control
groups, mosquitoes fed on recombinant PbPH-immunized
mice showed a significantly lower number of oocyst
intensity. Whereas the mean oocyst intensity was 100.5
in mosquitoes fed on control mice, it was almost halved
(52.3) in mosquitoes fed on PbPH-immunized mice
(Z = -5.28, P < 0.0001; Fig. 6c, Table 1). Further, mosquitoes
fed on control mice displayed an average infection
prevalence of 93.7 %, whereas it was reduced to 80.6 % in
mosquitoes fed on PbPH-immunized mice (OR = 3.571, 95
% CI = 1.631–7.818, P < 0.001; Table 1), demonstrating
modest TB activity of antibodies against recombinant
PbPH.
Discussion
Interrupting the development of a parasite inside its mos-
quito vector represents a key component of malaria control
strategies [33]. By mining the PlasmoDB, we identified a
gene PbPH that is expressed in sexual stages and character-
ized its functions in sexual development. The surface
localization of the PbPH protein on sexual stages prompted
us to evaluate its TB activities. Antisera against recombin-
ant PbPH were found to reduce the formation of male
gametes, block the formation of ookinetes in vitro, and
reduce the infection prevalence and oocyst density in
mosquito feeding experiments.
PbPH is a conserved membrane protein of Plasmodium
expressed in gametocytes, gametes, zygotes, and ookinetes.
Whereas the detection of expressed PbPH outside of the
cells is consistent with the presence of a signal peptide, the
lack of a putative GPI-anchor suggests that its association
with the membranes may be through interactions with the
membrane directly or with other membrane proteins. The
fact that the PH domains can bind phosphatidylinositol in
biological membranes [28] suggested that the surface locali-
zations of PbPH was probably achieved through direct
binding of the PbPH to phosphatidylinositol. PH domains
are commonly found in eukaryotic signal proteins. For
example, the calcium-dependent protein kinase PfCDPK7
from P. falciparum interacts with phosphatidylinositol
phosphate via its PH domain, which may guide its subcellu-
lar localization [34]. While how PbPH functions during
Plasmodium sexual development requires further investiga-
tions, gene disruption study demonstrated a role of PbPH in
gametocyte and gamete development, and possibly
subsequent maturation of ookinetes and their invasion
of the midgut epithelium.
Surface localization of the target during the sexual
stages of Plasmodium development is considered a key
parameter for the triage and selection of novel TBV
candidates [6]. The expression of PbPH on the surface
of sexual stages makes it a potential candidate for
TBV development. Its expression from gametocytes to
ookinetes suggests that antibodies against this protein
may interrupt parasite transmission at multiple steps.
First, the anti-PbPH antibodies may impede gametocyte
and gamete development. Consistently, the formation of
male gametes was significantly reduced during in vitro
incubation of gametocytes with the anti-PhPH antisera.
In addition, with the surface localization on both male
and female gametes, the anti-PbPH antiserum may
interfere with the interactions between the two sexes
and effectively prevent mating and formation of zygotes
[35]. Furthermore, PbPH was also expressed on the sur-
face of zygotes and ookinetes, suggesting that subsequent
transition and maturation of ookinetes may also be
affected. In reflecting this possibility, the number of
Table 1 Mosquito infection prevalence and oocyst intensity after feeding on control mice and mice immunized with recombinant PbPH
Control mice a PbPH-immunized mice a
M1 M2 M3 M4 M5 M1 M2 M3 M4 M5
Mosquitoes Infected/Dissected 28/25 28/27 29/27 30/29 29/27 30/24 32/27 31/25 30/24 32/25
Prevalence of infection (%) b 89.3 96.4 93.1 96.7 93.1 80 84.4 80.6 80 78.1
Mean prevalence (%) 93.72 80.62
Reduction in prevalence (%)c 13.1
Oocyst intensity d 96.5 98.70 106.80 106.60 93.97 54.10 49.53 46.65 58.39 52.94
SEM e 16.04 13.68 16.08 16.08 16.78 9.20 7.66 7.74 9.54 9.68
Mean oocyst intensity 100.51 52.32
Reduction in oocyst intensity f 47.95
a Five mice were used in each group for the evaluation of TB activity
b The prevalence of infection was calculated as the number of mosquitoes with oocysts/total mosquitoes dissected in each group × 100%
c The percent reduction of prevalence was calculated as % mean prevalence control – % mean prevalence PbPH
d Mean number of oocysts per mosquito midgut
e Standard error of the mean
f The percent reduction in oocyst intensity was calculated as (mean oocyst intensitycontrol – mean oocyst intensityPbPH)/mean oocyst intensity control × 100%
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ookinetes was drastically reduced in an in vitro ookinete
conversion assay. Finally, the presence of PbPH on the sur-
face of ookinetes, albeit at a much reduced level, suggests
that antibodies against PbPH may also inhibit the invasion
of the midgut epithelium in the mosquitoes. Altogether,
these are translated into reduced prevalence of infected
mosquitoes and oocyst density in mosquito feeding assays.
Collectively, PbPH could be potential TBV candidate
because of its expression in both pre- and post-
fertilization stages. Since pre-fertilization antigens are
targets of the natural immune responses, immunization
of the vertebrate hosts with such antigens may also help
boost naturally-occurring antibodies. This study demon-
strated evident TB activity of PbPH antibodies for
multiple developmental steps, which cooperatively lead
to significant reduction in mosquito infectivity. The high
levels of conservation of this protein in Plasmodium
highlight its potential as a target for TBV development
and warrants parallel studies in human malaria parasites.
Conclusions
In this study, we showed that pbph is a highly conserved
Plasmodium gene and PbPH protein localized it on the
surface of gametes, zygotes, retorts and ookinetes. Func-
tional studies of PbPH revealed that knockout of the
pbph gene can affect the formation of gametocytes,
gametes, ookinetes and oocysts. Anti-PbPH serum
significantly reduced the formation of male gametes and
ookinetes in vitro. Mosquitoes that fed on recombinant
PbPH protein-immunized mice showed significantly
lower oocyst intensity and infection prevalence com-
pared to that of a control group. In summary, these piv-
otal findings indicate that PbPH in Plasmodium is
essential for parasite transmission via mosquitoes and
this thus highlights its potential as a target for the devel-
opment of a transmission-blocking vaccine.
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